DEFA1 and COVID-19: Specifically, HBD-1 levels increase by 1.5 in pregnant women with COVID-19 when compared with controls (Figure 6A), while the levels of HBD-4 increase by 6.5 times in pregnant women with COVID-19 if compared to controls (Figure 6D), whereas HNP-1 level increase by 6.5 times in pregnant women with COVID-19 in comparison to controls (Figure 6E).